NCT00003694
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +13 more
- Locations
-
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT00003694
NCT00003190
NCT00047190
NCT00006363
NCT00049192
NCT00004905
NCT00060255
NCT00093639
NCT00739388
NCT00066326